You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 10, Issue 2

February 2018 - 31 articles

Cover Story: Pancreatic ductal adenocarcinoma (PDAC) is characterized by a very dense and highly organized tumor microenvironment (TME) consisting of extracellular matrix (ECM) proteins, cancer-associated fibroblasts (CAFs), pancreatic stellate cells (PSCs), and immune cells. At the epicenter of this dynamic and complex TME lies the cancer stem cell (CSC), which is believed to be the root of the tumor and the cell responsible for chemoresistance and disease relapse. We revisit the concept of the pancreatic CSC and discuss new advances in our understanding of its biology, properties and plasticity and address the concept of whether the CSC is a “state” or “entity”. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (31)

  • Review
  • Open Access
29 Citations
6,357 Views
11 Pages

21 February 2018

Current ovarian cancer screening guidelines in high-risk women vary according to different organizations. Risk reducing surgery remains the gold standard for definitive treatment in BRCA mutation carriers, but research advancements have created more...

  • Feature Paper
  • Article
  • Open Access
19 Citations
4,792 Views
11 Pages

Respiratory-Gated Proton Beam Therapy for Hepatocellular Carcinoma Adjacent to the Gastrointestinal Tract without Fiducial Markers

  • Miu Mizuhata,
  • Shigeyuki Takamatsu,
  • Satoshi Shibata,
  • Sayuri Bou,
  • Yoshitaka Sato,
  • Mariko Kawamura,
  • Satoko Asahi,
  • Yuji Tameshige,
  • Yoshikazu Maeda and
  • Makoto Sasaki
  • + 5 authors

21 February 2018

The efficacy of proton beam therapy (PBT) for hepatocellular carcinoma (HCC) has been reported, but insertion of fiducial markers in the liver is usually required. We evaluated the efficacy and toxicity of respiratory-gated PBT without fiducial marke...

  • Review
  • Open Access
39 Citations
6,789 Views
17 Pages

20 February 2018

Tumor mass is constituted by a heterogeneous group of cells, among which a key role is played by the cancer stem cells (CSCs), possessing high regenerative properties. CSCs directly metastasize to bone, since bone microenvironment represents a fertil...

  • Feature Paper
  • Article
  • Open Access
8 Citations
5,861 Views
16 Pages

Towards a Clinical Decision Support System for External Beam Radiation Oncology Prostate Cancer Patients: Proton vs. Photon Radiotherapy? A Radiobiological Study of Robustness and Stability

  • Seán Walsh,
  • Erik Roelofs,
  • Peter Kuess,
  • Yvonka Van Wijk,
  • Ben Vanneste,
  • Andre Dekker,
  • Philippe Lambin,
  • Bleddyn Jones,
  • Dietmar Georg and
  • Frank Verhaegen

18 February 2018

We present a methodology which can be utilized to select proton or photon radiotherapy in prostate cancer patients. Four state-of-the-art competing treatment modalities were compared (by way of an in silico trial) for a cohort of 25 prostate cancer p...

  • Article
  • Open Access
18 Citations
5,382 Views
12 Pages

17 February 2018

Epigenetic events and genetic alterations under the control of the tumor microenvironment potentially mediate tumor induced angiogenesis involved in soft tissue sarcoma (STS) metastasis. Addition of antiangiogenic agent, such as bevacizumab, to stand...

  • Review
  • Open Access
15 Citations
5,405 Views
16 Pages

17 February 2018

Pancreas cancer is a lethal cancer as the majority patients are diagnosed at an advanced incurable stage. Despite improvements in diagnostic modalities and management strategies, including surgery and chemotherapies, the outcome of pancreas cancer re...

  • Review
  • Open Access
26 Citations
7,239 Views
19 Pages

Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners

  • Paola Cappello,
  • Claudia Curcio,
  • Giorgia Mandili,
  • Cecilia Roux,
  • Sara Bulfamante and
  • Francesco Novelli

16 February 2018

Pancreatic Ductal Adenocarcinoma (PDA) is an almost incurable radio- and chemo-resistant tumor, and its microenvironment is characterized by a strong desmoplastic reaction associated with a significant infiltration of T regulatory lymphocytes and mye...

  • Review
  • Open Access
22 Citations
10,131 Views
17 Pages

Alleviating Pancreatic Cancer-Associated Pain Using Endoscopic Ultrasound-Guided Neurolysis

  • Kosuke Minaga,
  • Mamoru Takenaka,
  • Ken Kamata,
  • Tomoe Yoshikawa,
  • Atsushi Nakai,
  • Shunsuke Omoto,
  • Takeshi Miyata,
  • Kentaro Yamao,
  • Hajime Imai and
  • Hiroki Sakamoto
  • + 2 authors

15 February 2018

The most common symptom in patients with advanced pancreatic cancer is abdominal pain. This has traditionally been treated with nonsteroidal anti-inflammatory drugs and opioid analgesics. However, these treatments result in inadequate pain control or...

  • Review
  • Open Access
65 Citations
8,167 Views
9 Pages

Early Diagnosis to Improve the Poor Prognosis of Pancreatic Cancer

  • Masataka Kikuyama,
  • Terumi Kamisawa,
  • Sawako Kuruma,
  • Kazuro Chiba,
  • Shinya Kawaguchi,
  • Shuzo Terada and
  • Tatsunori Satoh

11 February 2018

Pancreatic cancer (PC) has a poor prognosis due to delayed diagnosis. Early diagnosis is the most important factor for improving prognosis. For early diagnosis of PC, patients with clinical manifestations suggestive of PC and high risk for developing...

of 4

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694